Get to know Lamina
Lamina Therapeutics biotech is developing a new generation of implantable medical devices combined with stem cells for osteochondral regenerative medicine
What we do ?
Lamina's Tech: A Game-Changer in Regenerative Medicine
Spin-off from INSERM - University of Strasbourg UMR1260 Regenerative Nanomedicine Founded by Pr. Nadia Benkirane-Jessel
Lamina Therapeutics Biotechnology start-up SAS created on 09-09-2020 SIRET Number: 88859264900022 3 patents licence Location: Campus Médecine, INSERM UMR 1260, CRBS building, 1 rue Eugène Boeckel 67000 Strasbourg, France
Meet the Lamina Team
-
Stephan Lemmens
CEO
-
Nadia Jessel
CSO - Founder
-
Rana Smaida
Project Manager
-
Jérémy Amzallag
QP Pharmacist
-
Nicolas Ferry
Reglementary Expert
-
Guoqiang Hua
Scientific Advisor
-
Morgane Meyer
PhD Student
-
Guillaume Conzatti
CMC Manager
-
Henri Favreau
Clinical Advisor
-
Christian Lutz
Clinical Advisor
-
Dominique Scipioni
Clinical Advisor
-
Katia Touzel
Finance
-
Matthieu Ehlinger
Scientific Board and Clinical Advisor
-
Philippe Rosset
Scientific Board
-
Didier Mainard
Scientific Board
-
Enrique Gomez Barrena
Scientific Board
Problem and Solution
Osteochondral damage in the knee affects 650 million people in the world (approximately 12 million in France), becoming an increasing medical problem. This damage is mostly caused by ageing and also joint injury affecting relatively young and active people, resulting in pain and mobility issues. Cartilage does not have self-healing capabilities and if left untreated this damage can lead to chronic osteoarthritis, a progressive disease with no cure today. There is a big need for innovative technologies to efficiently prevent cartilage degradation at an early stage and restore stable hyaline articular cartilage in localized chondral defects.
Lamina’s technology consists of a biodegradable medical device (MD) equipped with nanostructured reservoirs combined with bone marrow-derived healthy donor’s stem cells. Lamina. One product is a combined advanced therapy medicinal product (cATMP). This unique multifunctional approach offers a variety of potential applications addressing unmet medical needs in the field of orthopaedics, maxillofacial and periodontal lesions. With our Lamina. One product, we target both cartilage and bone regeneration.
